Table 4.
Frequency of ALT normalization by stratified variables.
| Variables | PPC group | MgIG group | p |
|---|---|---|---|
| Sex: male, n (missing) | 97 (0) | 96 (0) | 0.0538 |
| Yes | 39 (40.21%) | 26 (27.08%) | |
| No | 58 (59.79%) | 70 (72.92%) | |
| Sex: female, n (missing) | 77 (0) | 83 (0) | 0.0810 |
| Yes | 24 (31.17%) | 37 (44.58%) | |
| No | 53 (68.83%) | 46 (55.42%) | |
| Age<65 years, n (missing) | 151 (0) | 152 (0) | 0.4458 |
| Yes | 57 (37.75%) | 51 (33.55%) | |
| No | 94 (62.25%) | 101 (66.45%) | |
| Age>65 years, n (missing) | 27 (0) | 29 (0) | 0.0630 |
| Yes | 5 (18.52%) | 12 (41.38%) | |
| No | 22 (81.48%) | 17 (58.62%) | |
| ALT>3ULN, n (missing) | 96 (0) | 120 (0) | 0.3190 |
| Yes | 20 (20.83%) | 32 (26.67%) | |
| No | 76 (79.17%) | 88 (73.33%) | |
| ALT<3ULN, n (missing) | 87 (0) | 63 (0) | 0.9789 |
| Yes | 44 (50.57%) | 32 (50.79%) | |
| No | 43 (49.43%) | 31 (49.21%) | |
| Stop causative drug, n (missing) | 44 (0) | 50 (0) | 0.3082 |
| Yes | 14 (31.82%) | 21 (42.00%) | |
| No | 30 (68.18%) | 29 (58.00%) | |
| Continue causative drug, n (missing) | 139 (0) | 133 (0) | 0.5269 |
| Yes | 50 (35.97%) | 43 (32.33%) | |
| No | 89 (64.03%) | 90 (67.67%) | |
ALT, alanine aminotransferase; PPC, polyene phosphatidylcholine; MgIG, magnesium isoglycyrrhizinate; ULN, upper limit of normal.